Skip to NavigationSkip to content

real-world data

Reinventing the value equation

Published on 27/04/20 at 01:06pm

There is a duty to ensure access to innovative treatments for patients with unmet need, but a health service gatekeeper must commit to efficient use of limited resources. Matt Fellows looks at how real-world evidence could be the key to reassessing how we determine the value of these drugs and ensure their swift availability.

 

The April 2020 issue of Pharmafocus is available to read free online now!

The latest monthly edition of Pharmafocus, the April 2020 issue, is available to read for free online now!

There’s one big story on everyone’s mind, and with the whirlwind of information (and misinformation) around the COVID-19 pandemic, it’s easy to get disorientated. The latest issue of Pharmafocus aims to cut through that by providing a blow-by-blow account of some of the key milestones on the journey to where we are today.

Protecting public health: Is real-world evidence the key?

Published on 08/04/19 at 01:49pm

In often tough regulatory climates and with threats to public health are growing in sceptical corners of society, the need to deliver treatments and preventative therapies is a key concern for industry and national healthcare bodies. Matt Fellows explores how incorporating wider use of real-world evidence into these systems could be the solution we need.

Osteoporisis risk in over half of European women over 70, three-quarters not treated, Amgen study finds

A new study from Amgen analysing real-world data has revealed that more than half of European women over 70 years old are at risk of fragility fractures as a result of osteoporosis, while, shockingly, three-quarters of this number have not received treatment for the condition.

The study, which sought to assess the proportion of women who were at increased risk of fragility fracture and had not received osteoporosis medication, derived data from 3,798 women from eight European countries – Belgium, France, Germany, Ireland, Poland, Slovakia, Switzerland and the UK.

FDA turns to real-world evidence to improve regulatory process

The FDA has announced its intention to incorporate real-world data elements to a greater degree into its regulatory decision-making framework in a bid to “answer questions that are relevant to broader patient populations or treatment settings where information may not be captured through traditional clinical trials,” according to the agency’s Commissioner Scott Gottlieb.

The organisation is hoping to leverage a range of data sources including electronic health records, and billing, claims data and registry data in a bid to make more swift and robust decisions regarding the authoris

Real-world data: High on the life science agenda

Published on 03/05/17 at 12:46pm

John Wise of The Pistoia Alliance discusses the necessity of real-world data for a prosperous future for the life sciences industry, from encouraging collaboration to redefining drug valuation.

Real-World Evidence Forum

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches